Time to reconcile the dichotomy of the cardiovascular-placental axis
- PMID: 40168639
- DOI: 10.1002/uog.29207
Time to reconcile the dichotomy of the cardiovascular-placental axis
Comment on
-
N-terminal pro B-type natriuretic peptide as biomarker to predict pre-eclampsia and maternal-fetal complications.Ultrasound Obstet Gynecol. 2025 Apr;65(4):447-455. doi: 10.1002/uog.29202. Epub 2025 Mar 15. Ultrasound Obstet Gynecol. 2025. PMID: 40088200
References
REFERENCES
-
- Nan MN, Garrido‐Giménez C, Garcia‐Osuna A, et al. N‐terminal pro B‐type natriuretic peptide as biomarker to predict pre‐eclampsia and maternal–fetal complications. Ultrasound Obstet Gynecol. 2025;65(4):447‐455.
-
- Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992‐1005.
-
- Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt‐1: PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13‐22.
-
- Stepan H, Galindo A, Hund M, et al. Clinical utility of sFlt‐1 and PlGF in screening, prediction, diagnosis and monitoring of pre‐eclampsia and fetal growth restriction. Ultrasound Obstet Gynecol. 2023;61(2):168‐180.
-
- Lafuente‐Ganuza P, Carretero F, Lequerica‐Fernández P, et al. NT‐proBNP levels in preeclampsia, intrauterine growth restriction as well as in the prediction on an imminent delivery. Clin Chem Lab Med. 2021;59(6):1077‐1085.
Publication types
LinkOut - more resources
Full Text Sources
